Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.22	42.18	36.93
Graham Fair Price	-20.28	5.44	6.82
PEG	-89.51	-0.55	5.21
Price/Book	-21.95	2.89	3.70
Price/Cash Flow	-9.36	48.48	-53.49
Prices/Earnings	32.52	20.32	15.33
Price/Sales	-4.54	6.22	6.52
Price/FCF	-9.36	48.48	-53.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.21	0.30	0.30
Operating Margin	-20.67	0.12	0.15
ROA	-38.91	0.02	0.03
ROE	0.06	0.04	-41.10
ROIC	0.06	0.03	-39.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.18	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.09	-0.33	243.76
EPS QOQ	0.03	-0.37	1162.86
FCF QOQ	-5.31	1.89	-64.31
Revenue QOQ	0.12	-0.15	24.11
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	193.92	212.87	9.77
Days Sales Outstanding (DSO)	117.75	144.53	22.75
Inventory Turnover	0.46	0.42	-8.90
Debt/Capitalization	0.13	0.11	-13.54
Quick Ratio	0.88	0.89	1.83
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.86	6.09	3.87
Cash	1.21	0.90	-25.33
Capex	-0.52	0.00	inf
Free Cash Flow	-0.41	0.36	-10.54
Revenue	3.32	2.82	-15.06
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.62	1.65	2.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.03	-0.38	-1171.96
Naive Interpretation	Member

06 - Financial Health · Weak

Rating